Copyright
©The Author(s) 2021.
World J Gastroenterol. May 21, 2021; 27(19): 2353-2365
Published online May 21, 2021. doi: 10.3748/wjg.v27.i19.2353
Published online May 21, 2021. doi: 10.3748/wjg.v27.i19.2353
Bleeding group (n = 72) | Non-bleeding group (n = 267) | Matched OR (95%CI) | P value | |
Use of medications, n (%) | ||||
Corticosteroids | 19/72 (26.4) | 78/267 (29.2) | 0.82 (0.43-1.57) | 0.55 |
Thiopurines | 27/72 (37.5) | 108/267 (40.4) | 0.74 (0.36-1.51) | 0.40 |
Anti-TNF agents | 6/72 (8.3) | 27/267 (10.1) | 0.68 (0.24-1.91) | 0.47 |
Behavioral progression, n (%) | 10/58 (17.2) | 21/219 (9.6) | 1.96 (0.87-4.44) | 0.10 |
Intestinal resection, n (%) | 13/72 (18.1) | 30/267 (11.2) | 1.83 (0.73-4.58) | 0.20 |
- Citation: Yoon J, Kim DS, Kim YJ, Lee JW, Hong SW, Hwang HW, Hwang SW, Park SH, Yang DH, Ye BD, Byeon JS, Myung SJ, Yang SK. Risk factors and prognostic value of acute severe lower gastrointestinal bleeding in Crohn’s disease . World J Gastroenterol 2021; 27(19): 2353-2365
- URL: https://www.wjgnet.com/1007-9327/full/v27/i19/2353.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i19.2353